8. Huntington disease Clinical trials / Disease details
Clinical trials : 242 / Drugs : 205 - (DrugBank : 62) / Drug target genes : 85 - Drug target pathways : 159
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04698551 (ClinicalTrials.gov) | September 1, 2020 | 1/9/2020 | NIPD on cffDNA for Triplet Repeat Diseases | Comparison of Two NGS Phasing Techniques of Parental Haplotypes for NIPD of Triplet Expansion Diseases | Myotonic Dystrophy 1;Huntington Disease;Fragile X Syndrome | Genetic: Non invasive prenatal diagnosis | University Hospital, Montpellier | Agence de La Biomédecine | Active, not recruiting | 18 Months | N/A | All | 36 | France |